BR9815305A - Nucleic acid fragment, chimeric gene, host cell, polypeptide pad1, polypeptide jab1, method for changing the level of expression of a protein, method for obtaining a fragment of nucleic acid and product - Google Patents
Nucleic acid fragment, chimeric gene, host cell, polypeptide pad1, polypeptide jab1, method for changing the level of expression of a protein, method for obtaining a fragment of nucleic acid and productInfo
- Publication number
- BR9815305A BR9815305A BR9815305-6A BR9815305A BR9815305A BR 9815305 A BR9815305 A BR 9815305A BR 9815305 A BR9815305 A BR 9815305A BR 9815305 A BR9815305 A BR 9815305A
- Authority
- BR
- Brazil
- Prior art keywords
- nucleic acid
- fragment
- polypeptide
- expression
- protein
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 9
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 150000007523 nucleic acids Chemical group 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 102100032282 26S proteasome non-ATPase regulatory subunit 14 Human genes 0.000 title 1
- 101000590281 Homo sapiens 26S proteasome non-ATPase regulatory subunit 14 Proteins 0.000 title 1
- -1 host cell Proteins 0.000 title 1
- 108010018242 Transcription Factor AP-1 Proteins 0.000 abstract 2
- 102100023132 Transcription factor Jun Human genes 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 102000015936 AP-1 transcription factor Human genes 0.000 abstract 1
- 108050004195 AP-1 transcription factor Proteins 0.000 abstract 1
- 101100084902 Mus musculus Psmd14 gene Proteins 0.000 abstract 1
- 101150057849 Padi1 gene Proteins 0.000 abstract 1
- 230000010632 Transcription Factor Activity Effects 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
"FRAGMENTO DE áCIDO NUCLéICO, GENE QUIMéRICO, CéLULA HOSPEDEIRA, POLIPEPTìDIO Pad1, POLIPEPTìDIO Jab1, MéTODO PARA A ALTERAçãO DO NìVEL DE EXPRESSãO DE UMA PROTEìNA, MéTODO PARA A OBTENçãO DE UM FRAGMENTO DE áCIDO NUCLéICO E PRODUTO" A presente invenção refere-se a um fragmento de ácido nucléico que codifica uma proteína envolvida na regulação da atividade do fator de transcrição AP-1. A invenção também se refere à construção de um gene quimérico que codifica toda ou uma parte da protéina envolvida na regulação da atividade do fator de transcrição AP-1, na orientação de sentido ou anti-sentido, sendo que a expressão do gene quimérico resulta na produção de níveis alterados da proteína envolvida na regulação da atividade do fator de transcrição AP-1 em uma célula hospedeira transformada."FRAGMENT OF NUCLEIC ACID, CHEMICAL GENE, HOSTING CELL, POLYPEPTIODIO Pad1, POLIPEPTÍDIO Jab1, METHOD FOR CHANGING THE LEVEL OF EXPRESSION OF A PROTEIN, METHOD FOR GETTING A FOOD PROTECTION" a fragment of nucleic acid that encodes a protein involved in regulating the activity of the transcription factor AP-1. The invention also relates to the construction of a chimeric gene that encodes all or part of the protein involved in the regulation of the activity of the transcription factor AP-1, in sense or antisense orientation, and the expression of the chimeric gene results in production of altered levels of the protein involved in the regulation of AP-1 transcription factor activity in a transformed host cell.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6491497P | 1997-11-07 | 1997-11-07 | |
| PCT/US1998/023487 WO1999024574A2 (en) | 1997-11-07 | 1998-11-04 | Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815305A true BR9815305A (en) | 2001-02-13 |
Family
ID=22059097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815305-6A BR9815305A (en) | 1997-11-07 | 1998-11-04 | Nucleic acid fragment, chimeric gene, host cell, polypeptide pad1, polypeptide jab1, method for changing the level of expression of a protein, method for obtaining a fragment of nucleic acid and product |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1034274A2 (en) |
| AU (1) | AU1380499A (en) |
| BR (1) | BR9815305A (en) |
| WO (1) | WO1999024574A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7479555B2 (en) | 1999-07-21 | 2009-01-20 | Ceres, Inc. | Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity |
| DE29916160U1 (en) | 1999-09-14 | 2000-03-09 | Cardiogene Gentherapeutische Systeme AG, 40699 Erkrath | Modulation of gene transcription in vascular cells |
| US6599741B1 (en) | 1999-09-14 | 2003-07-29 | Avontec Gmbh | Modulating transcription of genes in vascular cells |
| DE19957065B4 (en) | 1999-11-26 | 2005-01-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Screening procedure for drugs |
| FR2806095A1 (en) * | 2000-03-10 | 2001-09-14 | Gentech | New polynucleotides for producing transgenic plants resistant to geminivirus infection comprising polynucleotides encoding proteins which interact with at least one of the products of the geminivirus genome |
| KR100602146B1 (en) | 2004-08-31 | 2006-07-19 | 학교법인 성균관대학 | Viral Infection Disease Therapeutic Compositions Containing VII1 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5942433A (en) * | 1995-07-31 | 1999-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
-
1998
- 1998-11-04 WO PCT/US1998/023487 patent/WO1999024574A2/en not_active Ceased
- 1998-11-04 EP EP98957575A patent/EP1034274A2/en not_active Withdrawn
- 1998-11-04 AU AU13804/99A patent/AU1380499A/en not_active Abandoned
- 1998-11-04 BR BR9815305-6A patent/BR9815305A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999024574A2 (en) | 1999-05-20 |
| EP1034274A2 (en) | 2000-09-13 |
| AU1380499A (en) | 1999-05-31 |
| WO1999024574A3 (en) | 1999-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908858A (en) | Isolated nucleic acid fragment, chimeric gene, transformed host cell, polypeptide, method of altering the level of expression of a protein, method of obtaining a fragment of nucleic acid and product. | |
| Fotia et al. | Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2 | |
| Yasukawa et al. | Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNALys with the MERRF encephalomyopathy pathogenic mutation | |
| Rampazzo et al. | A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease | |
| Veit et al. | Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain | |
| BR0115179A (en) | isolated polynucleotides, vector, recombinant DNA construction, method of transforming a cell, cell, method of producing a plant, plant, seed, isolated polypeptide and method for isolating a polypeptide | |
| Shaffer et al. | Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme. | |
| WO1995011984A3 (en) | Recombinant adenoviral vector and methods of use | |
| DK1005540T3 (en) | IKK-beta proteins, nucleic acids and methods | |
| BR9815632A (en) | Isolated nucleic acid fragment and method of obtaining it, chimeric gene, transformed host cell, method of altering the level of expression of an enzyme and product | |
| Chan et al. | Site-directed mutagenesis of human type X collagen: expression of α1 (X) NC1, NC2, and helical mutations in vitro and in transfected cells | |
| BR0115722A (en) | Floral development genes | |
| Hamill et al. | Purification of a WD repeat protein, EMAP, that promotes microtubule dynamics through an inhibition of rescue | |
| EP0756006A3 (en) | Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof | |
| Leyh et al. | GTPase-mediated activation of ATP sulfurylase. | |
| BR9815305A (en) | Nucleic acid fragment, chimeric gene, host cell, polypeptide pad1, polypeptide jab1, method for changing the level of expression of a protein, method for obtaining a fragment of nucleic acid and product | |
| Kesti et al. | Identification and tryptic cleavage of the catalytic core of HeLa and calf thymus DNA polymerase epsilon. | |
| Paiardini et al. | Threonine aldolase and alanine racemase: novel examples of convergent evolution in the superfamily of vitamin B6-dependent enzymes | |
| BR9813919A (en) | Isolated nucleic acid fragment, chimeric gene, transformed host cell, sclb ^ r ^ polypeptide, method for altering the expression level of a sclb ^ r ^ protein, method for obtaining a nucleic acid fragment and product | |
| BR9909414A (en) | Isolated nucleic acid fragment encoding all or a substantial part of a flavanone-3-hydroxylase, chimeric gene, trans-formed host cell, flavanone-3-hydroxylase polypeptide, method of altering the level of expression of a flavanone-3-hydroxylase in a host cell, method of obtaining a nucleic acid fragment encoding all or a substantial part of the amino acid sequence encoding a flavanone-3-hydroxylase, its product and method of evaluating the ability of at least one compound to inhibit activity of a flavanone-3-hydroxylase | |
| Shrimpton et al. | A TNNI2 mutation in a family with distal arthrogryposis type 2B | |
| BR9815065A (en) | Nucleic acid fragment, chimeric gene, host cell, isocitrate dehydrogenase polypeptide, method of altering the level of expression of an isocitrate dehydrogenase in a host cell, method of obtaining nucleic acid fragment, product and method of evaluating a compound to its ability to inhibit the activity of an isocitrate dehydrogenase | |
| ATE371744T1 (en) | FEEDBACK-RESISTANT HOMOSERINE TRANSSUCCINYLASES | |
| BR9815487A (en) | Isolated nucleic acid fragment, chimeric gene, transformed host cell, wheat 4-alpha-glucanotransferase polypeptide, method of altering the level of expression of a 4-alpha-glucanotransferase, method of obtaining a fragment of mucleic acid and product | |
| BR9907965A (en) | Isolated nucleic acid fragment, chimeric gene, transformed host cell, polypeptides, process of changing the level of expression of a cyclin protein in a host cell, method of obtaining a nucleic acid fragment, product and method of evaluating at least one compound as to its ability to inhibit the activity of a cyclin protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |